Shota Kakita, Tomohiro Matsuo, Asato Otsubo, Kyohei Araki, Hiroyuki Honda, Shintaro Mori et al. Phospho‐LATS1/2 Immunoreactivity and Survival in Muscle‐Invasive Bladder Cancer: A Quantitative Immunohistochemical Study. // International Journal of Urology. – 2026. – DOI: 10.1111/iju.70715. – URL: https://onlinelibrary.wiley.com/doi/10.1111/iju.70715?af=R
Shota Kakita, Tomohiro Matsuo, Asato Otsubo, Kyohei Araki, Hiroyuki Honda, Shintaro Mori, Kensuke Mitsunari, Kojiro Ohba, & Ryoichi Imamura (2026). Phospho‐LATS1/2 Immunoreactivity and Survival in Muscle‐Invasive Bladder Cancer: A Quantitative Immunohistochemical Study. International Journal of Urology. https://doi.org/10.1111/iju.70715
Shota Kakita, et al. “Phospho‐LATS1/2 Immunoreactivity and Survival in Muscle‐Invasive Bladder Cancer: A Quantitative Immunohistochemical Study.” International Journal of Urology, 2026. doi:10.1111/iju.70715.
@article{Kakita2026,
title = {Phospho‐LATS1/2 Immunoreactivity and Survival in Muscle‐Invasive Bladder Cancer: A Quantitative Immunohistochemical Study},
author = {Kakita, Shota and Matsuo, Tomohiro and Otsubo, Asato and Araki, Kyohei and Honda, Hiroyuki and Mori, Shintaro and Mitsunari, Kensuke and Ohba, Kojiro and Imamura, Ryoichi},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70715},
url = {https://onlinelibrary.wiley.com/doi/10.1111/iju.70715?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...